openPR Logo
Press release

Antigen Kit Market - Technical Breakthrough and a Competitive outlook to stay abreast on the key trends impacting this market by 2025

11-20-2017 10:32 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Antigen Kit Market - Technical Breakthrough and a Competitive

Antigens are used for the production of antibodies. These can be toxins or other substances, which induce an immune response in the body. Antigens are also known as antibodies. These are microbes such as bacteria, parasites, fungi, and other antigen such as pollen. Antigen kits are used to detect antigen of various diseases such as malaria, dengue, and influenza. Antigen test kits are primarily used in rapid medical diagnostics, in vitro diagnostic devices, and molecular diagnostics. Antibodies can be measured and detected from blood sample and saliva. Some antibody tests are useful to detect past infections or to diagnose a persisting infection.

Get PDF Brochure for more Professional & Technical industry insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29843

The global antigen kit market is expected to grow in the near future owing to increasing demand for antigen kit in various application segments such as rapid medical diagnostics, in vitro diagnostic device, and molecular diagnostics. Increasing prevalence of liver diseases, autoimmune diseases, and sexually transmitted diseases are expected to propel the growth of the antigen market during the forecast period. According to the American Autoimmune Related Diseases Association (AARDA) currently 50 million people in the U.S. are living with autoimmune diseases. Autoantibody/autoantigen tests are used to diagnose autoimmune disorders. These are also used to evaluate the severity of the condition and monitor effectiveness of treatment and relapses of the disorders. Autoantibody tests are performed when a patient is suffering from chronic, progressive arthritic symptoms, fatigue, fever, and muscle weakness. According to the World Health Organization, around 203 million cases of malaria were reported worldwide in 2012. The disease accounted for nearly 627,000 deaths globally in the same year. Cross-reaction and false negative results are likely to hamper the growth of the market during the forecast period.

The global antigen kit market has been segmented based on technique, application, end-user, and region. In terms of technique, the market has been categorized into precipitation reaction, agglutination reaction, complement fixation, immunofluorescent assay, enzyme-linked immunosorbent assay (ELISA), and radioimmunoassay. Based on application, the market has been divided into tropical diseases, liver diseases, autoimmune diseases, and sexually transmitted diseases. End-users in this market include hospitals, diagnostics centers, clinics, and others.

Geographically, the global antigen kit market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the largest market for antigen kits due to increasing prevalence of autoimmune diseases and rising incidence of sexually transmitted diseases. According to the Centers for Disease Control and Prevention (CDC), nearly 20 million new sexually transmitted infections occur in the U.S. each year, half among young people aged 15 years to 24 years, and account for nearly US$ 16 Bn in health care costs. Europe was the second largest market for antigen kits owing to increasing incidence of liver diseases. According to the European Association for the Study of the Liver, in 2013, liver cirrhosis accounted for 170,000 deaths in Europe and nearly 63,500 new cases of liver cancer were diagnosed in Europe in 2012. Acceptance and demand for high-end medical infrastructure are the major factors driving the market in Asia Pacific. China, Japan, and India are the fast growing markets in the region and are projected to fuel market growth. Countries in Latin America such as Brazil and Mexico have significant potential owing to evolving medical structure and high disposable income.

Request for an in-depth table of contents for this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=29843

Major players operating in the antigen kit market include Thermo Fisher Scientific, SD BIOSENSOR, Inc., SinoBiological, Inc., Cell Biolabs, Inc., Affinity Biologicals Inc., R-Biopharm AG, Epitope Diagnostics, Inc., and Oxford BioMedica.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
90 State Street,
Suite 700
Albany NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
E-mail: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antigen Kit Market - Technical Breakthrough and a Competitive outlook to stay abreast on the key trends impacting this market by 2025 here

News-ID: 823918 • Views:

More Releases from Transparency Market Research

Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion by 2036, Driven by Rising Opioid Use and Targeted Therapies
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion …
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronic
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product Type / By Impact Frequency | China • India • Japan • U.S.
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T …
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compound
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Billion in 2025 to US$ 244.4 Billion at 27% CAGR
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil …
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036. This growth trajectory reflects the transition of automobiles from mechanically driven products to
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable Drug Demand
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable …
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,

All 5 Releases


More Releases for Antigen

Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: Cr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing carcinoembryonic antigen has experienced swift expansion lately, projected to progress from a valuation of $1.22 billion in 2024 to $1.38 billion the following year, reflecting a robust compound annual growth rate of
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market? The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)
COVID-19 Antigen Test Market Report 2024 - COVID-19 Antigen Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global COVID-19 Antigen Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, the covid-19 antigen
COVID-19 Antigen Test Market Report 2024 - COVID-19 Antigen Test Market Size And …
"The Business Research Company recently released a comprehensive report on the Global COVID-19 Antigen Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The covid-19 antigen
CEACAM8 Antigen Gene Market Unveiling the Enigma: The CEACAM8 Antigen Gene Marke …
CEACAM8 Antigen Gene Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CEACAM8 Antigen Gene Market Size, Share & Trends Analysis Report By Type (Above 95%, Above 99%, Others), By Application (Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions, Others)- Market Outlook And Industry Analysis 2031" The Global CEACAM8 Antigen Gene Market is estimated